Literature DB >> 25796198

Berberine reduces Toll-like receptor-mediated macrophage migration by suppression of Src enhancement.

Wei-Erh Cheng1, Miao Ying Chang2, Jyun-Yan Wei3, Yen-Jen Chen4, Ming-Chei Maa5, Tzeng-Horng Leu6.   

Abstract

Berberine is an isoquinoline with anti-inflammatory activity. We previously demonstrated that there was a loop of signal amplification between nuclear factor kappa B and Src for macrophage mobility triggered by the engagement of Toll-like receptors (TLRs). The simultaneous suppression of lipopolysaccharide (LPS)-mediated upregulation of inducible nitric oxide synthase, cyclooxygenase 2, and cell mobility in berberine-treated macrophages suggested Src might be a target of berberine. Indeed, th reduced migration, greatly suppressed Src induction in both protein and RNA transcript by berberine were observed in macrophages exposed to LPS, peptidoglycan, polyinosinic-polycytidylic acid, and CpG-oligodeoxynucleotides. In addition to Src induction, berberine also inhibited LPS-mediated Src activation in Src overexpressing macrophages and S-nitroso-N-acetylpenicillamine (a nitric oxide donor) could partly restore it. Moreover, berberine suppressed Src activity in fibronectin-stimulated macrophages and in v-Src transformed cells. These results implied that by effectively reducing Src expression and activity, berberine inhibited TLR-mediated cell motility in macrophages.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Berberine; Berberine (PubChem CID: 2353); LPS (PubChem CID: 53481793); Macrophage migration; SNAP (PubChem CID: 5231); Src; Thioglycollate (PubChem CID: 5086465); Toll-like receptor

Mesh:

Substances:

Year:  2015        PMID: 25796198     DOI: 10.1016/j.ejphar.2015.03.013

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 2.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

Review 3.  Nutraceutical therapies for atherosclerosis.

Authors:  Joe W E Moss; Dipak P Ramji
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

4.  Suppression of NFAT5-mediated Inflammation and Chronic Arthritis by Novel κB-binding Inhibitors.

Authors:  Eun-Jin Han; Hyun Young Kim; Naeun Lee; Nam-Hoon Kim; Seung-Ah Yoo; H Moo Kwon; Dae-Myung Jue; Yune-Jung Park; Chul-Soo Cho; Tran Quang De; Dae Young Jeong; Hee-Jong Lim; Woo Kyu Park; Ge Hyeong Lee; Heeyeong Cho; Wan-Uk Kim
Journal:  EBioMedicine       Date:  2017-03-31       Impact factor: 8.143

Review 5.  The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway.

Authors:  Chung-Yi Chen; Chiu-Li Kao; Chi-Ming Liu
Journal:  Int J Mol Sci       Date:  2018-09-12       Impact factor: 5.923

Review 6.  Nanotechnological approach to delivering nutraceuticals as promising drug candidates for the treatment of atherosclerosis.

Authors:  Sindhu C Pillai; Ankita Borah; Eden Mariam Jacob; D Sakthi Kumar
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

7.  Berberine Attenuates Macrophages Infiltration in Intracranial Aneurysms Potentially Through FAK/Grp78/UPR Axis.

Authors:  Kai Quan; Sichen Li; Dongdong Wang; Yuan Shi; Zixiao Yang; Jianping Song; Yanlong Tian; Yingjun Liu; Zhiyuan Fan; Wei Zhu
Journal:  Front Pharmacol       Date:  2018-05-30       Impact factor: 5.810

8.  Effect of berberine on lipopolysaccharide-induced monocyte chemotactic protein-1 and interleukin-8 expression in a human retinal pigment epithelial cell line.

Authors:  Hu-Shan Cui; Yu-Min Li; Wei Fang; Jiu-Ke Li; Yuan-Min Dai; Lian-Shun Zheng
Journal:  Int Ophthalmol       Date:  2017-08-29       Impact factor: 2.031

9.  Effectiveness and Safety of Dietetic Supplementation of a New Nutraceutical on Lipid Profile and Serum Inflammation Biomarkers in Hypercholesterolemic Patients.

Authors:  Graziano Riccioni; Maria Alessandra Gammone; Walter Currenti; Nicolantonio D'Orazio
Journal:  Molecules       Date:  2018-05-14       Impact factor: 4.411

10.  Lipopolysaccharide-Induced Matrix Metalloproteinase-9 Expression Associated with Cell Migration in Rat Brain Astrocytes.

Authors:  Chien-Chung Yang; Chih-Chung Lin; Li-Der Hsiao; Jing-Ming Kuo; Hui-Ching Tseng; Chuen-Mao Yang
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.